Home » Stocks » PARD

Poniard Pharmaceuticals, Inc. (PARD)

Stock Price: $0.0700 USD 0.0000 (0.00%)
Updated Apr 13, 2021 9:30 AM EDT - Market closed
Market Cap 434,756
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 1.50M
EPS (ttm) -3.79
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 13
Last Price $0.0700
Previous Close $0.0700
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.0700
Day's Range 0.0700 - 0.0700
Day's Volume 0
52-Week Range 0.0300 - 0.1200

News

There are no news available yet.

About PARD

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic ... [Read more...]

Industry
Biotechnology
IPO Date
Aug 11, 1988
Stock Exchange
OTCMKTS
Ticker Symbol
PARD
Full Company Profile